Over 80 firms are involved in providing antibody drug discovery-related services; whereas close to 1

According to experts in this field, the industry is investigating antibodies against novel targets which are expected to drive the market in the coming years. In fact, many service provider and platform provider companies are offering support to the medical research community in order to develop an appropriate intervention to treat the illness caused by the SARS-CoV-2 virus.

Leave a Reply

Your email address will not be published. Required fields are marked *